ABVX:EPA
Abivax SA
76,75 €
arrow_upward
+0,13%(+0,100) 1 d
19 nov., 13:58:40 GMT+1 · EUR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för ABVX …
Öppen
77,35 €
Högt
77,40 €
Lågt
76,40 €
Börsvärde
6,72 md
Genomsn. vol.
110,41 tn
Volym
10,89 tn
52v högst
139,00 €
52v lägst
60,45 €
EPS
−5,20 €
Utestående aktier
87,55 mn
Antal anställda
98
Öppen
77,35 €
Högt
77,40 €
Lågt
76,40 €
Börsvärde
6,72 md
Genomsn. vol.
110,41 tn
Volym
10,89 tn
52v högst
139,00 €
52v lägst
60,45 €
EPS
−5,20 €
Utestående aktier
87,55 mn
Antal anställda
98
Nyheter och artiklar
Från webbkällor och nyhetspartner
MarketWatch
·
för 22 minuter sedan
Stock Market Today: Nasdaq to lead Dow and S&P 500 higher as tech rallies on Anthropic IPO optimism; Nvidia stock gains; Walmart earnings on tap: live updates
Yahoo Finance
·
för 3 timmar sedan
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
The Motley Fool
·
för 16 timmar sedan
ExxonMobil (XOM) Just Achieved Something 95% of S&P 500 (GSPC) Members Haven't Done
Investor's Business Daily
·
för 1 timme sedan
4 S&P 500 Stocks Paying Plump Dividends Double — And Don't Need AI
Profil
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
Om Abivax SA
VdMarc de Garidel | Hartmut J. Ehrlich
Anställda98
Grundades4 dec. 2013
Huvudkontor-
SektorHealth Care
Bransch-
Webbplatsabivax.com